Abstract
Fibrous dysplasia is a developmental disorder of the bone that originates from a genetic defect disturbing the osteogenesis leading to the replacement of normal bone with the excess proliferation of fibrous tissue. It can be associated with hyperpigmentation of the skin and endocrine disorders. Fibrous dysplasia can manifest in a monostotic form affecting one bone or in a polyostotic form involving several bones. Approximately 30% of monostotic forms are observed in the maxilla and the mandible. It frequently appears in the posterior region and is usually unilateral. It is found in teenagers and could become static after adulthood. Patients can present with swelling, facial asymmetry, pain, or numbness on the affected side. Treatment modalities vary between conservative surgical treatment, radical surgical approach, and medical treatment based on bisphosphonates. Here, we present a case of a monostotic form of fibrous dysplasia affecting the posterior left region of the mandible in a 9-year-old male complaining of gradually increased swelling on the left mandibular side of one-year duration. The diagnosis of fibrous dysplasia is established based on clinical, radiographical, and histopathological features. Conservative surgery is implemented with surgical shaving and reencountering of the bone excess to reduce the facial asymmetry. Recurrence is reported 10 years later and is also treated with a localized osteoplasty and remodeling of the bone contours. Five years later, the lesion remains stable. In conclusion, a conservative approach should be adopted as the first line of treatment for young patients suffering from monostotic fibrous dysplasia.
1. Introduction
Fibrous dysplasia (FD) is a benign intraosseous tumor-like process, where the medullary bone is substituted by fibrous connective tissue leading to undeveloped and inadequately calcified bone [1–4]. FD involves an inequity among osteoblastic and osteoclastic activities triggered by a genetic mutation in the stimulatory G protein (GSα) [5].
The increase in the activity of GSα in osteoblast progenitor cells and osteoclasts is stimulated by the amplified production of interleukin-6 stromal cells [5–7].
According to the current World Health Organization classification of bone tumors, FD belongs to tumors with an undefined neoplastic nature [4]. FD can be associated with hormonal dysregulations, most frequently precocious puberty with cutaneous manifestations seen in the McCune-Albright syndrome, MAS, or intramuscular myxomas in Mazabraud's syndrome, MS [1, 2]. FD commonly develops in the first or second decades of life, affects women more than men with a ratio of 2 : 1, and is usually asymptomatic with very low evolution [1, 2]. FD occurs either as a monostotic form affecting a single bone or as a polyostotic form spreading into several bones [1–4]. Monostotic fibrous dysplasia (MFD) is around 10 times more common than polyostotic fibrous dysplasia (PFD) and is frequently unilateral [3, 4]. The lack of stable bone matrix formation can manifest in a multitude of ways, involving facial distortion and asymmetry [5–7]. In the jaws, tooth movement, occlusion problems, pain, paresthesia, and interference with dental eruption can be observed [3]. Rapid growth of the bone lesion as well as an increase in the level of alkaline phosphatase could be indicators to possible malignant transformation [2].
In this manuscript, we report a case of MFD in the mandible of a 9-year-old male patient. The diagnosis is established based on different imaging techniques and confirmed with biopsy. Surgery for bone remodeling to correct the patient's facial contour is the treatment adopted.
2. Case Report
A 9-year-old male presented to our clinics with his parents complaining of swelling and asymmetry in the left side of his mandible.
The questionnaires revealed that the expansion of the swelling was slow, gradually increasing during the past year with no pain reported.
Extraoral examination showed a mild facial asymmetry associated with a well-defined swelling on the left side of the mandible measuring 3 to 4 cm (Figure 1(a)). No cutaneous pigmentations on the face, no limitations of mouth opening, and no enlarged submandibular lymph nodes were noticed.
Intraoral examination displayed expansion of the buccal cortical plate, extending from the mandibular left incisal to the first molar, and the first deciduous molar was absent (Figure 1(b)). On palpation, it was hard in constancy, fixed, with no signs of mucosal inflammation observed and no signs of paresthesia.
A panoramic radiograph exposed the loss of trabecular structure and a radiopaque image showing a “ground-glass” feature was observed on the left side of the mandible englobing the dental germ of the permanent second premolar (Figure 1(c)).
The cone-beam computed tomography (CBCT) axial images revealed a radiopacity lesion with an expansion and thinning of the buccal bone cortical with well-defined borders (Figure 1(d)). The dental germ was in the middle of the lesion (Figure 1(e)), and the para-axial images showed the mandibular canal displaced buccally and toward the lower border of the mandible (Figure 1(f)).
Based on the evaluation of the clinical and radiological data, a provisional diagnosis of FD was made, and differential diagnoses of MAS, MS, and hyperparathyroidism were considered.
As the germ needed to be removed, we discussed with the parents the surgical procedure required to extract the germ along with the need for an osteoplasty to remove the excess bone and a biopsy to be taken during the procedure.
Under locoregional analgesia, a conservative surgical excision of the buccal bone was proceeded, with extraction of the dental germ and remodeling of the region disturbed by the asymmetry (Figure 2(a)). Macroscopically, the excised bone was soft with spongy aspects (Figure 2(b)). The histological results were consistent with FD. The hematoxylin-eosin staining revealed irregularly shaped trabeculae of immature bone within proliferating fibroblastic and vascularized stroma (Figure 2(c)).
The patient was advised to consult his pediatrician for further clinical and radiological investigations. All the laboratory tests and radiological images were in favor of localized FD mandibular lesions.
The patient was followed up yearly, both clinically and radiologically with a panoramic radiograph (Figures 2(d) and 2(e)).
Ten years later, the patient complained of left mandibular asymmetry (Figure 3(a)).
Clinical examination revealed a lingual cortical bone expansion beside the buccal one (Figures 3(b) and 3(c)).
Panoramic X-ray showed the same image of a radiopaque area with the appearance of ground glass aspects in the left hemimandible (Figure 3(d)).
The axial images of the CBCT presented a discontinuity of the buccal cortex, expansion of the lingual one, and expansion of the lesion anteriorly to the middle line of the mandible.
The mandibular canal was still displaced to the lower border of the mandible (Figure 3(e)).
A 3D reconstruction showed an increase in the volume of the left hemimandible, confirming mandibular asymmetry (Figure 3(f)).
After discussing the findings with the patient, a second surgery was decided. Under locoregional analgesia, a wide osteoplasty was performed, and the buccal bone was reshaped until the limit of the mental nerve anteriorly and the position of the mandibular canal apically (Figures 4(a) and 4(b)). The histology results confirmed the previous one.
No complications were recorded in the follow-up period, and the patient was satisfied with the esthetic results (Figure 4(c)).
Five years later the clinical and radiological exams showed a stabilization of the lesion (Figures 4(d)–4(f)).
3. Discussion
FD represents 7% of all benign bone tumors and includes the facial bones in approximately 10%–27% of MFD patients [1–4]. Chen et al. state that MFD affects the maxilla more regularly than the mandible [8]. Kruse et al. reveal that equal distribution between the maxilla and the mandible exists [9]. Lee et al. show that the mandible is touched in 19 cases and the maxilla in 6 [10]. Davidova et al. report that maxilla (23/38) is more involved than the mandible (15/38) [11].
The differential diagnosis of FD comprises simple bone cyst, nonossifying fibroma, osseous-fibrous dysplasia, adamantinoma, low-grade intramedullary osteosarcoma, Paget's disease, MAS, and MS [1, 10, 11].
The CBCT offers complete information about the bone lesions associated with the FD, its border, and the exact relation with the anatomical elements [8].
Treatment modalities of FD such as conservative surgery [9, 10, 12, 13], radical excision [14, 15], and medical treatment with bisphosphonates [16, 17] are suggested. Conservative surgical management implicates surgical excision of the poorly mineralized bone followed by a modeling osteoplasty through an intraoral approach which can potentially help with the histological confirmation of the diagnosis [9, 10, 12, 13]. The surgical treatment should take into consideration the age of the patient [4, 9].
The recurrence of fibrous dysplasia is reported in relation to puberty or skeletal maturation; however, its evolution is constant into adulthood [1, 4, 9].
Kruse et al. describe the treatment of MFD in 8 patients with a modeling osteotomy with good results [9]. Valentini et al. state that, in a retrospective study involving 95 patients with FD situated in the craniomaxillofacial area, the following proportions are seen: 76% MFD, 22% PFD, and 2% McCune-Albright syndrome. Of 95 patients, surgical treatment is done for only 68 patients (radical removal of the affected bone for 62 patients and conservative treatment for 6 patients); the remaining patients refused surgery although the authors suggest that radical surgery avoids recurrence [15].
The use of bisphosphonates to decrease osteoclastic activities is considered as a treatment option apart from surgery [16, 17]. Intravenous, not oral, bisphosphonates can be considered in the treatment of persistent, moderate to severe bone pain [18]. Lala et al. state that the use of bisphosphonates improves the clinical situation in children and adults [17]. To note, osteonecrosis of the jaws is a major complication of bisphosphonate treatment [18, 19]. Thus, caution should be considered when prescribing bisphosphonates for a long period in patients suffering from FD [19].
In our case, the patient is young, and the diagnosis is based on clinical, radiological, and histological data. Since the asymmetry is disturbing to the patient, conservative surgical approach is adopted keeping in mind that he is 9 years old, around puberty with a skeletal system that is still in a growth period. At this age, radical excision is very traumatic and can affect the facial growth of the patient. Also, the use of bisphosphonates does not significantly impact the age-dependent decrease in bone turnover, and it does not prevent the progression of FD disease burden in young as stated by Florenzano et al [18]. The CBCT images are very useful to delimitate the lesions, especially when near the mental foramen in the mandibular canal.
Recurrence is observed ten years later, and bone remodeling is adopted for the reasons previously mentioned. Five years later, the clinical situation is stable, and the patient remains satisfied with the esthetic results.
4. Conclusion
Conservative treatment for MFD should be considered, particularly if the patient is young. Localized surgical excision of the demineralized bone followed by an osteoplasty and contour remodeling is one of the most conservative approaches for the treatment of asymmetry. Observation and follow-up should be maintained closely.
Consent
Parents signed the consent form before the first surgery. Patient signed the consent form before the second surgery.
Conflicts of Interest
The authors do not have any financial interests, either directly or indirectly, in the products or information listed in this paper.
References
- 1.Ozek C., Gundogan H., Bilkay U., Tokat C., Gurler T., Songur E. Craniomaxillofacial fibrous dysplasia. The Journal of Craniofacial Surgery. 2002;13(3):382–389. doi: 10.1097/00001665-200205000-00004. [DOI] [PubMed] [Google Scholar]
- 2.DiCaprio M. R., Enneking W. F. Fibrous dysplasia, pathophysiology, evaluation, and treatment. The Journal of Bone and Joint Surgery. American. 2005;87(8):p. 1848. doi: 10.2106/JBJS.D.02942. [DOI] [PubMed] [Google Scholar]
- 3.Burke A. B., Collins M. T., Boyce A. M. Fibrous dysplasia of bone: craniofacial and dental implications. Oral Diseases. 2017;23(6):697–708. doi: 10.1111/odi.12563. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Sweeney K., Kaban L. B. Natural history and progression of craniofacial fibrous dysplasia: a retrospective evaluation of 114 patients from Massachusetts General Hospital. Journal of Oral and Maxillofacial Surgery. 2020;78(11):1966–1980. doi: 10.1016/j.joms.2020.05.036. [DOI] [PubMed] [Google Scholar]
- 5.Ramaswamy G., Kim H., Zhang D., et al. Gsα controls cortical bone quality by regulating osteoclast differentiation via cAMP/PKA and β-catenin pathways. Scientific Reports. 2017;7(1, article 45140) doi: 10.1038/srep45140. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Riminucci M., Kuznetsov S. A., Cherman N., Corsi A., Bianco P., Robey P. G. Osteoclastogenesis in fibrous dysplasia of bone: in situ and in vitro analysis of IL-6 expression. Bone. 2003;33(3):434–442. doi: 10.1016/s8756-3282(03)00064-4. [DOI] [PubMed] [Google Scholar]
- 7.Cleven A. H. G., Schreuder W. H., Groen E., Kroon H. M., Baumhoer D. Molecular findings in maxillofacial bone tumours and its diagnostic value. Virchows Archiv. 2020;476(1):159–174. doi: 10.1007/s00428-019-02726-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Chen Y. R., Wong F. H., Hsueh C., Lo L. J. Computed tomography characteristics of non-syndromic craniofacial fibrous dysplasia. Chang Gung Medical Journal. 2002;25(1):1–8. [PubMed] [Google Scholar]
- 9.Kruse A., Pieles U., Riener M. O., Zunker C., Bredell M. G., Grätz K. W. Craniomaxillofacial fibrous dysplasia: a 10-year database 1996-2006. The British Journal of Oral & Maxillofacial Surgery. 2009;47(4):302–305. doi: 10.1016/j.bjoms.2009.01.008. [DOI] [PubMed] [Google Scholar]
- 10.Lee J. S., FitzGibbon E., Chen Y. R., et al. Clinical guidelines for the management of craniofacial fibrous dysplasia. Orphanet Journal of Rare Diseases. 2012;7(Supplement 1) doi: 10.1186/1750-1172-7-S1-S2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Davidova L. A., Bhattacharyya I., Islam M. N., Cohen D. M., Fitzpatrick S. G. An analysis of clinical and histopathologic features of fibrous dysplasia of the jaws: a series of 40 cases and review of literature. Head and Neck Pathology. 2020;14(2):353–361. doi: 10.1007/s12105-019-01039-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.De Melo W. M., Sonoda C. K., Hochuli-Vieira E. Monostotic fibrous dysplasia of the mandible. The Journal of Craniofacial Surgery. 2012;23(5):e452–e454. doi: 10.1097/SCS.0b013e318262d9b1. [DOI] [PubMed] [Google Scholar]
- 13.Alves N., de Oliveira R. J., Takehana D., Deana N. F. Recurrent monostotic fibrous dysplasia in the mandible. Case Reports in Dentistry. 2016;2016:6. doi: 10.1155/2016/3920850.3920850 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Zenn M. R., Zuniga J. Treatment of fibrous dysplasia of the mandible with radical excision and immediate reconstruction: case report. The Journal of Craniofacial Surgery. 2001;12(3):259–263. doi: 10.1097/00001665-200105000-00012. [DOI] [PubMed] [Google Scholar]
- 15.Valentini V., Cassoni A., Marianetti T. M., Terenzi V., Fadda M. T., Iannetti G. Craniomaxillofacial fibrous dysplasia: conservative treatment or radical surgery? A retrospective study on 68 patients. Plastic and Reconstructive Surgery. 2009;123(2):653–660. doi: 10.1097/PRS.0b013e318196bbbe. [DOI] [PubMed] [Google Scholar]
- 16.Mäkitie A. A., Törnwall J., Mäkitie O. Bisphosphonate treatment in craniofacial fibrous dysplasia--a case report and review of the literature. Clinical Rheumatology. 2008;27(6):809–812. doi: 10.1007/s10067-008-0842-z. [DOI] [PubMed] [Google Scholar]
- 17.Lala R., Matarazzo P., Bertelloni S., Buzi F., Rigon F., de Sanctis C. Pamidronate treatment of bone fibrous dysplasia in nine children with McCune-Albright syndrome. Acta Paediatrica. 2000;89(2):188–193. doi: 10.1080/080352500750028816. [DOI] [PubMed] [Google Scholar]
- 18.Florenzano P., Pan K. S., Brown S. M., et al. Age-related changes and effects of bisphosphonates on bone turnover and disease progression in fibrous dysplasia of bone. Journal of Bone and Mineral Research. 2019;34(4):653–660. doi: 10.1002/jbmr.3649. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Metwally T., Burke A., Tsai J. Y., Collins M. T., Boyce A. M. Fibrous dysplasia and medication-related osteonecrosis of the jaw. Journal of Oral and Maxillofacial Surgery. 2016;74(10):1983–1999. doi: 10.1016/j.joms.2016.04.001. [DOI] [PMC free article] [PubMed] [Google Scholar]